We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo






  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-4 of 4

Proposed amendment would exempt some generic submissions from Canada’s PM(NOC) regulations

  • Torys LLP
  • -
  • Canada
  • -
  • October 4 2011

Health Canada has released a proposed amendment to its guidance document Patented Medicines (Notice of Compliance) Regulations

Doing a deal with pharma

  • Torys LLP
  • -
  • Canada
  • -
  • August 4 2011

From the perspective of the biotech company, there are several legal and business issues to consider when doing a deal with big pharma

Federal Court of Canada grants data protection to an old medicinal ingredient

  • Torys LLP
  • -
  • Canada
  • -
  • February 14 2012

In a recent decision Celgene Inc. v. Canada (Minister of Health) the Federal Court of Canada declared that a drug containing a previously approved medicinal ingredient is nevertheless subject to data protection

Health Canada’s guidance document on PM(NOC) Regulations now finalized

  • Torys LLP
  • -
  • Canada
  • -
  • April 4 2012

Health Canada has published an update to its guidance document on the application of the Patented Medicines (Notice of Compliance) Regulations

Current Search

Suggested Facets

Author

Workarea

© Copyright 2006-2013 Globe Business Publishing Ltd | Cookies | Disclaimer | Privacy policy